MLchartDataset catalogue

von Hippel-Lindau peptide vaccine

Term · Oncology and biomedicine · MLC-T-ONC-017530

A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein.

Table 1. Record
IdentifierMLC-T-ONC-017530
FieldOncology and biomedicine
SynonymsVHL Peptides; VHL peptide vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-017530",
  "term": "von Hippel-Lindau peptide vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein.",
  "synonyms": [
    "VHL Peptides",
    "VHL peptide vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/von-hippel-lindau-peptide-vaccine/"
}

Record 17,333 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.